Singletto has filed a notice of an exempt offering of securities to raise $10,000,000.00 in New Debt Financing.
According to filings with the U.S. Securities and Exchange Commission, Singletto is raising up to $10,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, John Bjornson played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Singletto
Active Protection from Pathogens. Confidence to Live Well. Singlettos novel Oxafence technology is being developed to meet the needs of healthcare, military, industry, and consumers – providing ongoing Active Protection from pathogens where it matters most. Early in the COVID-19 pandemic, Singletto Co-Founder Dr. James (Jim) Chen hypothesized that Photodynamic Therapy (PDT) methods could be deployed for mask and Personal Protective Equipment (PPE) decontamination. PDT has long been deployed medically to treat cancer and skin disease. Chen, a neurosurgeon, has spent thirty years researching and applying various methods of PDT in diverse areas, including oncology, ophthalmology, dermatology, obesity, and for inflammatory conditions. As the world faced mask and PPE shortages, Chen’s hypothesis offered hope for healthcare and frontline workers being forced to reuse and extend the use of their single-use masks and PPE. The method also showed potential as a preventative measure to protect masks and PPE from becoming infected in the first place. Chen and Singletto Co-Founder and pediatric surgeon Dr. Thomas (Tom) Lendvay approached global health leaders who initiated worldwide research that confirmed the theory. Drs. Chen and Lendvay, together with John Bjornson and others, founded Singletto to further develop the technology to address the many unmet needs of healthcare, military, industry, and consumers.
To learn more about Singletto, visit http://www.singletto.com/
Contact:
John Bjornson, Chief Executive Officer
206-222-8825
https://www.linkedin.com/in/john-bjornson/
SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.